MILZA HOWARD: Open Payments
NPI 1699396325 · OPELIKA, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$382 in 17 payments from 8 companies in 2025. Trend: 2023 $18 · 2024 $214 · 2025 $382
Food & beverage: $382
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 3 | $81 |
| Otsuka America Pharmaceutical, Inc. | 4 | $81 |
| Vanda Pharmaceuticals Inc. | 2 | $58 |
| Alkermes, Inc. | 3 | $58 |
| Axsome Therapeutics, Inc. | 2 | $38 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $25 |
| Lundbeck LLC | 1 | $22 |
| E.R. Squibb & Sons, L.L.C. | 1 | $20 |
Products named: INGREZZA, ABILIFY MAINTENA, FANAPT, ARISTADA, Auvelity, CAPLYTA, REXULTI, COBENFY.
Industry payments across AL — which companies pay providers there.
